International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and sells cosmetic active and natural health ingredients for use in various consumer products in Europe, Africa, the Middle East, Greater Asia, North America, and Latin America. It operates through Nourish, Scent, Health & Biosciences, and Pharma Solutions segments. The Nourish segment offers natural and plant-based specialty food ingredients, such as flavor compounds, and savory solutions and inclusions. It also provides natural food protection ingredients consist of natural antioxidants and anti-microbials as well as beverages, sweets , and dairy products. The Scent segment provides fragrance compounds, which include fine fragrances comprising perfumes and colognes, as well as consumer fragrances; fragrance ingredients comprising synthetic and natural ingredients that could be combined with other materials to create fragrance and consumer compounds; and cosmetic active ingredients consisting of active and functional ingredients, botanicals, and delivery systems to support its customers' cosmetic and personal care product lines.[ Read More ]
The intrinsic value of one IFF stock under the base case scenario is HIDDEN Compared to the current market price of 86.1 USD, International Flavors & Fragrances Inc. is HIDDEN
Current Assets | 6.29 B |
Cash & Short-Term Investments | 703 M |
Receivables | 2.09 B |
Other Current Assets | 3.5 B |
Non-Current Assets | 24.7 B |
Long-Term Investments | 52 M |
PP&E | 4.96 B |
Other Non-Current Assets | 19.7 B |
Current Liabilities | 3.76 B |
Accounts Payable | 1.38 B |
Short-Term Debt | 970 M |
Other Current Liabilities | 1.41 B |
Non-Current Liabilities | 12.6 B |
Long-Term Debt | 9.85 B |
Other Non-Current Liabilities | 2.73 B |
Revenue | 11.5 B |
Cost Of Revenue | 7.8 B |
Gross Profit | 3.68 B |
Operating Expenses | 5.79 B |
Operating Income | 831 M |
Other Expenses | 3.4 B |
Net Income | -2.56 B |
Net Income | -2.56 B |
Depreciation & Amortization | 1.14 B |
Capital Expenditures | -503 M |
Stock-Based Compensation | 65 M |
Change in Working Capital | 485 M |
Others | 2.55 B |
Free Cash Flow | 936 M |
Date | Value | Insider | Amount | Avg Price |
---|---|---|---|---|
6 days ago
Nov 11, 2024
|
Sell 459 K USD
|
Arora Yuvraj
President, Nourish |
- 5000
|
91.755 USD |
5 months ago
Jun 13, 2024
|
Sell 248 K USD
|
Strzelecki Angela
President, Pharma Solutions |
- 2588
|
95.657 USD |
1 year ago
May 11, 2023
|
Sell 170 K USD
|
Fauchon de Villeplee Christophe
President, Scent |
- 1972
|
86.35 USD |
2 years ago
Aug 11, 2022
|
Sell 1.25 M USD
|
Fortanet Francisco
EVP, Operations |
- 10000
|
125 USD |
2 years ago
Jun 01, 2022
|
Sell 83.4 K USD
|
Fauchon de Villeplee Christophe
President, Scent |
- 629
|
132.59 USD |
2 years ago
May 02, 2022
|
Sell 76.7 K USD
|
Fauchon de Villeplee Christophe
President, Scent |
- 630
|
121.68 USD |
3 years ago
May 13, 2021
|
Sell 184 K USD
|
Herriott Simon
President Health & Biosciences |
- 1332
|
138.47 USD |
3 years ago
May 14, 2021
|
Bought 140 K USD
|
GORDON ILENE S
Director |
+ 1000
|
140.3857 USD |